120 likes | 212 Vues
Explore ethical considerations, justice issues, and fair participation in vaccine policy, addressing global challenges and evolving norms. Delve into the role of industry, public trust-building, evidence utilization, and emerging global shifts in vaccine discussions.
E N D
Key Ethics Themes and Questions from CVEP Philadelphia May, 202X Meeting Preliminary Caplan summary!!
What is the Ethic of Vaccines? • All lives will be treated as of equal value • Are vaccines public goods and when and why? • Is a human rights framework constructive? • What is a population and public health ethics for vaccines and do we really mean to continue to use/insist upon it in a world where individualistic thinking may be on the rise?
What is the Right Ethic for Vaccines? • Can a focus on vaccines stand alone as part of a broad public health ethic • Do children deserve priority in all vaccine policy and why? • How does profit stack up morally in the realm of vaccines?
How to Have Fair Participation • Is local control the best strategy for input and accountability as against regional? • Does proliferation of local bodies help or hinder access to safe and effective vaccines? • How should civil society voices be heard in vaccine policy? • Is their sufficient accountability and transparency in a Gates funded world?
Justice • How does the emphasis on vaccines complement or distort need to improve health care infrastructure in very poor nations? • Does asking govts to match Gates goals unduly distort other public health needs being met? • Is industry doing enough in terms of charitable behavior toward those in need. • What are the long term fiscal/infrastructure strategies that can sustain cost-effective and locally desired vaccines?
Justice • Should international vaccine policy be disconnected from vaccine policy in developed world • Justice of eradication efforts • Are the ‘distribution’ ethics of getting access to proven vaccines where there is a huge need the same as getting vaccine to meet a limited but real need in a poor nation or poor populations?
Justice • How can internal access and equity be achieved within nations? Who enforces it? With what degree of respect for local values?
Choice • Does the vaccine community need to adopt a new moral stance toward personal choice regarding vaccines? • Is ‘choice’ by countries, communities and individuals to be real? How informed, how voluntary? Mandates? • What factors build public trust in vaccines and how do they vary by community and context? • New risk/benefit calculus in doing research including new vaccines but also social and economic experiments
Evidence and COI • What is COI in the vaccine domain and how should it be thought about and managed? • Is industry all of a piece in thinking of conflict of interest vaccine scientists vs. marketing • Is evidence being used properly in setting vaccine policy comparisons of what? • Are we using the right tools and metrics for vaccines QALYs, DALYs, what??? NHS v USA
Emerging Challenges • How do new behavioral and therapeutic vaccines challenge ability of existing regulatory bodies and public understanding and attitudes about vaccines? • How will rapid development of India, China, Brazil, Argentina and other nations alter traditional norms about vaccine policy outside North America and Europe? • Can existing vaccine organizations do their jobs in the wake of the Gates’ initiatives • Who is left standing in a post-Gates, 202x world?
Emerging Challenges • Are we learning from failure, i.e., Have we resolved emergency ethics for pandemics including sharing of samples and access for all or those most in need in public health crises?